Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

<p>Knockdown of lncRNA MCM3AP-AS1 Attenuates Chemoresistance of Burkitt Lymphoma to Doxorubicin Treatment via Targeting the miR-15a/EIF4E Axis</p>
Chao Guo, Ming Gong, Zhenling Li
Cancer Management and Research (2020) Vol. Volume 12, pp. 5845-5855
Open Access | Times Cited: 23

Showing 23 citing articles:

Long non-coding RNAs in the doxorubicin resistance of cancer cells
Saeed Ashrafizaveh, Milad Ashrafizadeh, Ali Zarrabi, et al.
Cancer Letters (2021) Vol. 508, pp. 104-114
Open Access | Times Cited: 150
The Role of LncRNAs in Translation
Didem Karakaş, Bülent Özpolat
Non-Coding RNA (2021) Vol. 7, Iss. 1, pp. 16-16
Open Access | Times Cited: 78
Long non-coding RNAs as the critical regulators of doxorubicin resistance in tumor cells
Ghazaleh Khalili‐Tanha, Meysam Moghbeli
Cellular & Molecular Biology Letters (2021) Vol. 26, Iss. 1
Open Access | Times Cited: 47
Crosstalk between lncRNAs in the apoptotic pathway and therapeutic targets in cancer
Nasim Ebrahimi, Sahar Parkhideh, Setare Samizade, et al.
Cytokine & Growth Factor Reviews (2022) Vol. 65, pp. 61-74
Closed Access | Times Cited: 29
Insights into the Role of LncRNAs and miRNAs in Glioma Progression and Their Potential as Novel Therapeutic Targets
Mateusz Kciuk, Esam Bashir Yahya, Montaha Mohamed Ibrahim Mohamed, et al.
Cancers (2023) Vol. 15, Iss. 13, pp. 3298-3298
Open Access | Times Cited: 18
Fourth Report on Chicken Genes and Chromosomes 2022
Jacqueline Smith, James M. Alfieri, Nick Anthony, et al.
Cytogenetic and Genome Research (2022) Vol. 162, Iss. 8-9, pp. 405-528
Open Access | Times Cited: 26
Long non‐coding RNA as a novel biomarker and therapeutic target in aggressive B‐cell non‐Hodgkin lymphoma: A systematic review
Shaghayegh Khanmohammadi, Parisa Fallahtafti
Journal of Cellular and Molecular Medicine (2023) Vol. 27, Iss. 14, pp. 1928-1946
Open Access | Times Cited: 12
MicroRNA and Other Non-Coding RNAs in Epstein–Barr Virus-Associated Cancers
Kin Israel Notarte, Suranga L Senanayake, Imee Macaranas, et al.
Cancers (2021) Vol. 13, Iss. 15, pp. 3909-3909
Open Access | Times Cited: 29
Long Non-Coding RNA Signatures in Lymphopoiesis and Lymphoid Malignancies
Hamed Baghdadi, Reza Heidari, Mahdi Zavvar, et al.
Non-Coding RNA (2023) Vol. 9, Iss. 4, pp. 44-44
Open Access | Times Cited: 8
LncRNA MCM3AP-AS1 promotes chemoresistance in triple-negative breast cancer through the miR-524-5p/RBM39 axis
Yueping Wang, Xuedong Wang, Sun Haiyi, et al.
Molecular and Cellular Biochemistry (2024)
Closed Access | Times Cited: 2
A review on the role of MCM3AP-AS1 in the carcinogenesis and tumor progression
Soudeh Ghafouri‐Fard, Tayyebeh Khoshbakht, Bashdar Mahmud Hussen, et al.
Cancer Cell International (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 10
The role of LncRNA MCM3AP-AS1 in human cancer
Shirin Azizidoost, Farhoodeh Ghaedrahmati, Mohadeseh Sheykhi-Sabzehpoush, et al.
Clinical & Translational Oncology (2022) Vol. 25, Iss. 1, pp. 33-47
Closed Access | Times Cited: 9
MCM3AP-AS1: An Indispensable Cancer-Related LncRNA
Xiao Yu, Qingyuan Zheng, Qiyao Zhang, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 12
Long non-coding RNAs with essential roles in neurodegenerative disorders
Wandi Xiong, Linlin Lu, Jiali Li
Neural Regeneration Research (2023) Vol. 19, Iss. 6, pp. 1212-1220
Open Access | Times Cited: 3
Potential Role of miRNAs in the Acquisition of Chemoresistance in Neuroblastoma
Barbara Marengo, Alessandra Pulliero, Maria Valeria Corrias, et al.
Journal of Personalized Medicine (2021) Vol. 11, Iss. 2, pp. 107-107
Open Access | Times Cited: 7
miRNA- and lncRNA-Based Therapeutics for Non-Hodgkin’s Lymphoma: Moving towards an RNA-Guided Precision Medicine
Mara Fernandes, Herlander Marques, Ana Luísa Teixeira, et al.
Cancers (2021) Vol. 13, Iss. 24, pp. 6324-6324
Open Access | Times Cited: 6
Unraveling the Role of Long Non-Coding RNAs in Therapeutic Resistance in Acute Myeloid Leukemia: New Prospects & Challenges
Siddhant Sharma
Non-coding RNA Research (2024) Vol. 9, Iss. 4, pp. 1203-1221
Open Access
MCM3AP-AS1: A LncRNA Participating in the Tumorigenesis of Cancer Through Multiple Pathways
Chengfu Yuan, Bei Wang, Jinlan Chen, et al.
Mini-Reviews in Medicinal Chemistry (2022) Vol. 22, Iss. 16, pp. 2138-2145
Closed Access | Times Cited: 3
Long Non-Coding RNA MCM3AP-AS1: A Crucial Role in Human Malignancies
Tao Ma, Fahong Wu, Hongxia Wu, et al.
Pathology & Oncology Research (2022) Vol. 28
Open Access | Times Cited: 3
Competitive Endogenous RNA Network Involving miRNA and lncRNA in Non-Hodgkin Lymphoma: Current Advances and Clinical Perspectives
Mara Fernandes, Herlander Marques, Ana Luísa Teixeira, et al.
Biomedicines (2021) Vol. 9, Iss. 12, pp. 1934-1934
Open Access | Times Cited: 3
lncRNA-miRNA-mRNA Interaction Networks Regulation in Hematological Malignancies
Heriberto Prado-Garcı́a, Ana Elizabeth González‐Santiago, Susana Romero-García, et al.
Elsevier eBooks (2023), pp. 373-397
Closed Access
The Prognostic Value of lncRNA MCM3AP-AS1 on Clinical Outcomes in Various Cancers: A Meta- and Bioinformatics Analysis
Liangyin Fu, Guangming Zhang, Yongfeng Wang, et al.
Disease Markers (2022) Vol. 2022, pp. 1-16
Open Access
Prognostic Analysis of LncRNA MCM3AP-AS1 in Colorectal Cancer and the Mechanism of Its Effect on Tumor Cell Activity
Song Qi, Jinsuo Gao, Jinzhu Yang, et al.
BioMed Research International (2022) Vol. 2022, pp. 1-13
Open Access
Page 1

Scroll to top